Trial Profile
A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Apr 2016
Price :
$35
*
At a glance
- Drugs Hypericin sodium (Primary)
- Indications Herpes labialis
- Focus Adverse reactions
- Sponsors Yung Shin Pharmaceutical
- 13 Apr 2016 Status changed from recruiting to completed.
- 08 Aug 2014 New trial record